Abstract P3-10-07: A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trialSP Gampenrieder, Richard Greil, Marie E. Steiner et al.|Cancer Research|2019Cited by 0
ErratumKaren K. S. Sunahara, Romy Zemel, Paulina Sannomiya et al.|Cellular Physiology and Biochemistry|2012Cited by 0